Financials

News Ideas Discussions Technicals Forecast Seasonals

1093/N fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to CSPC PHARMACEUTICAL GROUP LIMITED operating, investing, and financing activities

1093/N free cash flow for H2 24 is 5.03 B MXN. For 2024, 1093/N free cash flow was 7.78 B MXN and operating cash flow was 13.94 B MXN.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: MXN

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—